EUVIMEDEUVIMED entdecken
Crossref

ISL1 Restricts Progenitor Programs and Promotes β-Cell Maturation, Revealing Sex Differences in Diabetes Progression

Valeria Fabriciova iD, Romana Bohuslavova iD, Laura Lebron-Mora iD, Vera Slaninova iD, Pavel Abaffy iD, Zuzana Berkova iD, Frantisek Saudek iD, Klaus H Kaestner iD, Gabriela Pavlinkova iD

Diabetes · 2026

DOI: 10.2337/db25-0673 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, 2026. Verfasst von Valeria Fabriciova und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Pathogenetics, Institute of Biotechnology, Czech Academy of Sciences (CAS), Prague, Czechia. Hauptthemen laut MEDLINE: LIM-Homeodomain Proteins, Insulin-Secreting Cells, Transcription Factors, Stem Cells. Gefördert von: European Union, Czech Academy of Sciences, Czech Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic islet cells differentiate from a common progenitor pool through tightly regulated transcriptional and epigenetic programs. ISL1, a LIM homeodomain transcription factor, is essential for islet development, but its molecular functions remain poorly defined. Here, we demonstrate that ISL1 is critical for maintaining endocrine cell identity and enabling terminal differentiation, particularly of α- and β-cells. Using conditional Isl1 deletion in endocrine precursors, combined with single-cell RNA sequencing and chromatin profiling (H3K27ac and H3K27me3), we reveal disruption of the transcriptional and epigenetic landscape in Isl1-deficient islets. Loss of Isl1 results in the failure to establish α-cell identity, loss of δ- and γ-cell lineages, and the persistence of immature β-cells with impaired functional profiles in Isl1CKO mice. Longitudinal single-cell analysis shows that Isl1CKO endocrine cells exhibit sustained progenitor-like states and defective β-cell maturation. These defects are accompanied by activation of stress and diabetes-associated transcriptional programs, along with sex-specific responses that may influence disease onset and progression. Mechanistically, ISL1 represses intermediate progenitor programs and facilitates chromatin remodeling necessary for endocrine lineage commitment and terminal maturation. Our findings highlight a previously underappreciated role for ISL1 in preserving endocrine cell fate and function and offer insight into how its dysregulation may contribute to diabetes. Article Highlights ISL1 is a known maturity-onset diabetes of the young candidate and type 2 diabetes susceptibility gene, yet its molecular role in pancreatic endocrine maturation has remained unresolved. Deletion of Isl1 in endocrine progenitors results in islets composed of dysfunctional α-cells lacking glucagon production and immature β-cells with impaired basal insulin secretion, ultimately accelerating diabetes progression. ISL1 functions as a transcriptional repressor guiding chromatin remodeling and transcriptional transitions toward hormone-producing endocrine cells. The metabolic phenotype resulting from Isl1 deletion is associated with sustained progenitor-like states and activation of diabetes- and stress-associated pathways, with distinct sex-specific responses observed between male and female mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LIM-Homeodomain ProteinsInsulin-Secreting CellsTranscription FactorsStem CellsAnimalsMiceMaleFemaleCell DifferentiationGlucagon-Secreting CellsSex CharacteristicsDisease ProgressionMice, Knockout

Substanzen

LIM-Homeodomain ProteinsTranscription Factorsinsulin gene enhancer binding protein Isl-1

Autor:innen und Institutionen

  • Laboratory of Molecular Pathogenetics, Institute of Biotechnology, Czech Academy of Sciences (CAS), Prague, Czechia.
  • Faculty of Science, Charles University, Prague, Czechia.
  • Laboratory of Gene Expression, Institute of Biotechnology, CAS, Prague, Czechia.
  • Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czechia.
  • Department of Genetics and Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.

ORCID-Profile: Valeria Fabriciova, Romana Bohuslavova, Laura Lebron-Mora, Vera Slaninova, Pavel Abaffy, Zuzana Berkova, Frantisek Saudek, Klaus H Kaestner, Gabriela Pavlinkova

Förderung

  • European Union
  • Czech Academy of Sciences
  • Czech Science Foundation
  • Agency of Charles University
  • MEYS
  • ESIF
  • GeneCore Facility at BIOCEV
  • EU

Zitieren

APA

Fabriciova, V., Bohuslavova, R., Lebron-Mora, L., Slaninova, V., Abaffy, P., Berkova, Z., Saudek, F., Kaestner, K. H., & Pavlinkova, G. (2026). ISL1 Restricts Progenitor Programs and Promotes β-Cell Maturation, Revealing Sex Differences in Diabetes Progression. Diabetes. https://doi.org/10.2337/db25-0673

Vancouver

Fabriciova V, Bohuslavova R, Lebron-Mora L, Slaninova V, Abaffy P, Berkova Z, et al. ISL1 Restricts Progenitor Programs and Promotes β-Cell Maturation, Revealing Sex Differences in Diabetes Progression. Diabetes. 2026. doi:10.2337/db25-0673

BibTeX
@article{Fabriciova2026,
  author = {Fabriciova, Valeria and Bohuslavova, Romana and Lebron-Mora, Laura and Slaninova, Vera and Abaffy, Pavel and Berkova, Zuzana and Saudek, Frantisek and Kaestner, Klaus H and Pavlinkova, Gabriela},
  title = {ISL1 Restricts Progenitor Programs and Promotes β-Cell Maturation, Revealing Sex Differences in Diabetes Progression},
  journal = {Diabetes},
  year = {2026},
  doi = {10.2337/db25-0673}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche